Clinical fracture incidence in metastatic hormone-sensitive prostate cancer and risk-reduction following addition of zoledronic acid to androgen deprivation therapy with or without docetaxel: Long-term results from the STAMPEDE trial
European Urology（2023）
关键词
zoledronic acid,clinical fracture incidence,prostate cancer,hormone-sensitive,risk-reduction,long-term
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要